Safety and Effectiveness of Zemplar Injection in Decreasing iPTH Levels in Pediatric ESRD Subjects on Hemodialysis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2002
The purpose of this study is to see if Zemplar, a vitamin D medication, safely and effectively decreases parathyroid hormone in children ages 2-20 with End Stage Renal Disease.
Epistemonikos ID: 49ad98d3c32d78a6de686c4f2258a0c8863e5ab6
First added on: May 04, 2024